Parmax Pharma Peer Comparison

BSE: 540359

₹137.75

₹-1.35 (-0.97%)

As on 12-Oct-2026IST

Market cap

₹95 Cr

Revenue (TTM)

₹18 Cr

P/E Ratio

--

P/B Ratio

13.9

Div. Yield

0 %

Edit

	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality	Aether
Market cap (₹ Cr)	95	69	46	33,294	22,785
Revenue (₹ Cr)	18	1	35	4,974	1,224
Net Profit (₹ Cr)	-1.19	1.49	5.90	804.14	235.19
Net Margin (%)	-5.82	67.60	15.67	15.54	18.79
RoE (%)	--	3.36	14.76	18.21	10.03
Price to Earnings	--	45.91	7.81	41.66	96.88
Price-To-Book	13.94	1.50	1.11	6.75	9.06

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality	Aether
Operating Revenue	18.39	1.47	35.09	4,974.29	1,223.90
Total Income	20.51	2.21	37.68	5,175.21	1,251.61
Total Expenditure	20.90	0.36	28.94	3,969.25	839.85
EBITDA	-2.51	1.11	6.15	1,005.04	384.05
Depreciation	1.25	0.02	0.46	74.82	73.63
EBIT	-3.76	1.09	5.69	930.22	310.42
Interest	1.24	0.07	0.32	70.95	18.87
Other Income	2.12	0.74	2.59	200.92	27.71
Exceptional Items	0.00	0.00	0.00	0.00	-6.34
Profit before Tax	-2.88	1.76	7.97	1,060.19	312.91
Provision for Tax	-1.69	0.27	2.06	256.05	77.72
Profit after Tax	-1.19	1.49	5.90	804.14	235.19

Liabilities (₹ Cr)

	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality	Aether
Shareholder's Funds	-6.15	45.01	40.88	4,706.68	2,455.89
Minority Interest	0.00	0.00	0.00	-4.97	0.00
Non-Current Liabilities	11.52	1.46	0.41	308.16	88.20
Current Liabilities	22.68	0.62	6.60	1,236.15	657.34
Total Liabilities	18.75	46.92	43.07	5,100.22	--

Assets (₹ Cr)

	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality	Aether
Non-Current Assets	11.38	12.06	2.36	3,202.99	1,754.09
Current Assets	16.68	35.04	45.34	2,823.52	1,171.47
Total Assets	18.75	46.92	43.07	5,100.22	--
Total Debt*	8.09	0.90	4.21	308.70	--
Net Current Assets	-6.00	34.42	38.74	1,587.37	514.14
Contingent Liabilities	--	0.41	1.09	50.60	--

Cashflow (₹ Cr)

	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality	Aether
Cash From Operating Activities	-0.96	2.11	-5.83	446.86	--
Cash Flow from Investing Activities	-0.70	-20.97	0.46	-235.20	--
Cash from Financing Activities	1.40	43.67	1.35	-271.49	--
Net Cash Inflow / Outflow	-0.26	24.81	-4.02	-59.84	--

Ratios

Profitability Ratios

	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality	Aether
ROCE (%)	-29.88	2.44	16.58	22.17	--
ROE (%)	0.00	3.36	14.76	18.21	10.03
ROA (%)	-5.10	3.18	12.98	14.67	8.05
EBIT Margin (%)	-20.44	74.42	16.22	18.70	25.36
Net Margin (%)	-5.82	67.60	15.67	15.54	18.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality	Aether
Revenue Growth (%)	21.10	261.18	3.45	9.80	33.72
EBIT Growth (%)	-111.89	228.86	81.36	9.36	34.90
Net Profit Growth (%)	64.45	344.12	50.00	31.47	34.01
EPS Growth (%)	51.58	290.99	50.00	27.82	30.29
Book Value Growth (%)	-346.40	3,563.74	11.34	19.46	--

Valuation Ratios

	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality	Aether
Price / Earnings	0.00	45.91	7.81	41.47	94.91
Price / Book Value	-5.86	1.50	1.11	6.75	9.06
Dividend Yield (%)	0.00	0.00	1.38	0.12	0.00
EV/EBITDA	80.88	39.74	6.97	33.03	60.46
Market Cap (₹ Cr)	15.80	61.28	73.37	20,933.97	--

Solvency Ratios

	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality	Aether
Debt to Equity	-1.87	0.02	0.01	0.00	0.00
Short term debt to equity ratio	--	--	0.10	0.08	--
Current Ratio	0.74	56.24	6.87	2.28	1.78
Quick Ratio	0.39	56.24	6.64	1.67	0.96
Interest Coverage	-1.32	24.78	26.21	15.94	17.58

Operating Efficiency Ratios

	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality	Aether
Debtors to sales (%)	17.20	25.24	21.25	14.00	31.87
Asset Turnover	0.79	0.03	0.77	0.91	0.42
Receivable days	20.01	49.30	55.72	50.98	--
Inventory Days	36.94	0.00	19.39	50.95	--
Payable days	149.20	74.11	45.04	46.50	--
Cash Conversion Cycle	-92.25	-24.81	30.08	55.43	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly